Citadel Advisors’s TransCode Therapeutics RNAZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-28
| Closed | -$25.6K | – | 6558 |
|
|
2024
Q2 | $25.6K | Buy |
+28
| New | +$25.6K | ﹤0.01% | 5352 |
|
|
2024
Q1 | – | Sell |
-8
| Closed | -$46.5K | – | 6733 |
|
|
2023
Q4 | $46.5K | Buy |
+8
| New | +$46.5K | ﹤0.01% | 5146 |
|
|
2021
Q4 | – | Hold |
0
| – | -$271K | – | 7067 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5107 |
|